TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below.
If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener:
http://www.thestreet.com/k/qr/flat/stock-screener.html
Upgrades: CORT, CVGI, EPD, EXAR, GAIA, ORIG
Downgrades: CMO, DCI, ESP, FCFS, FSLR, OA, PLAB, SR
Initiations: None
Read on to get TheStreet Quant Ratings' detailed report:

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 1,176,495 share increase in total short interest for Corcept Therapeutics Inc , to 4,521,614, an increase of 35.17% since 12/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the May 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Investors in Corcept Therapeutics Inc saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new October 16th contracts and identified the following put contract of particular interest.

Investors in Corcept Therapeutics Inc saw new options become available this week, for the February 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Investors in Corcept Therapeutics Inc saw new options become available this week, for the November 22nd expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 236 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.